News In Brief
This article was originally published in The Gray Sheet
ReGen seeks bankruptcy protection
You may also be interested in...
ReGen Biologics says it is considering several last-ditch options to keep its collagen meniscus scaffold device on the U.S. market, but they do not include another hearing with FDA.